What weight loss products are available at DOZA?

DOZA offers programs with Ozempic (semaglutide), Retatrutide, Biopatid, and peptides — each product is selected individually. A specialist will evaluate your situation free of charge.

What results can be expected with Ozempic (semaglutide)?

Ozempic (semaglutide 0.5–2 mg/week) delivers an average weight loss of 10–15% over 6 months. DOZA clients report sustained appetite reduction after just 1–2 injections.

What is Retatrutide and what results does it show?

Retatrutide is a triple GLP-1/GIP/glucagon agonist. In Phase 3 TRIUMPH-1 (topline 2026), participants on 12 mg lost an average of 28.3% body weight over 80 weeks — the highest result among GLP-1 agonists studied. Phase 2 (NEJM 2023): up to 24.2% over 48 weeks.

How do I sign up for the DOZA program?

Message us on Telegram {botHandle} — a specialist will evaluate your situation and select a product free of charge. Response within 5 minutes.

DOZA client reviews — real weight loss results

Client Results

Reviews about weight loss

Real weight loss results from people who completed the program with DOZA and Mounjaro

💉 Mounjaro reviews 💬 Ask on Telegram

💬 Real conversations📱 Telegram screenshots✅ Verified

⭐Client Results

Reviews about weight loss

Real weight loss results from people who completed the program with DOZA and Mounjaro

💉 Mounjaro reviews 💊 Ozempic reviews 🔬 Retatrutide reviews 🧬 Biopatid statement

💬Real conversations

📱Telegram screenshots

✅Verified

👥2147+clients on program

⭐4.6service rating

🌡️2–8°Cthermo delivery

🕐24/7specialist support

2 147+

Clients

−1,026 kg

Total weight lost

25%

Lost over 10 kg (report)

4.6/5

Google Maps rating

Nataliia

34 years

-10 KG•2 months

Review Nataliya — Mounjaro review about weight loss -10 kg | DOZA

1/2

✓

Verified

Real client

34 years

Anastasia

31 years

-9 KG•3 months

Review Anastasia — Mounjaro review about weight loss -9 kg | DOZA

✓

Verified

Real client

31 years

Irina

42 years

-9.3 KG•5 weeks

Review Iryna — Mounjaro review about weight loss -9.3 kg | DOZA

✓

Verified

Real client

42 years

Frequently asked questions

Yes. All reviews are real client conversations from Telegram, uploaded directly from the chat. We do not edit texts and only publish verified results.

Valentyna Tytorenko

Diploma-certified endocrinologist, certified dietitian and nutritionist

Want the same result?

Free consultation with a specialist. We'll find a program that delivers results for you.

Start program

⚕️

Important information

The information on this page is for educational and informational purposes. It is not a substitute for individual specialist consultation. Self-medication is unsafe — always consider contraindications.

•Weight loss results are individual and depend on your body's characteristics, the chosen program, and adherence to recommendations.
•Clinical data (SURMOUNT-1, STEP-1) were obtained under controlled conditions and may differ from real-world practice.
•Mounjaro (tirzepatide) is a product by Eli Lilly. The FDA approved tirzepatide for type 2 diabetes as Mounjaro (2022) and separately for weight management as Zepbound (2023). The EMA (2023) and MHRA (2023) authorised Mounjaro for both indications. It has contraindications. Before starting, we recommend specialist consultation.
•DOZA statistics (2,147+ clients, 4.6/5 Google Maps) are internal data. The Outcomes Report (n=163, −1,026 kg) contains self-reported client data — dated but not a clinical trial.

Certificates Licenses Research Terms of service